Stem Cell Research & Therapy operates using a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Manuscripts submitted to Stem Cell Research & Therapy will be evaluated initially by the Editors-in-Chief, and then assigned to an Associate Editor who is responsible for designating at least 2 reviewers in order to assess the scientific quality of the submitted material. The reviewers' comments will be considered by the Associate Editor and Editors-in-Chief and a final decision on publication will be made. They consider the quality of the manuscript from a scientific standpoint and its importance and significance in view of the scope of Stem Cell Research & Therapy.
2017 Journal Metrics
54.9 days from submission to first decision for reviewed manuscripts only
51.3 days to first decision for all manuscripts
120.7 days from submission to acceptance
28.0 days from acceptance to publication
825 Altmetric mentions